| Literature DB >> 24204176 |
Sh Talib1, Sr Bhattu, R Bhattu, Sg Deshpande, Db Dahiphale.
Abstract
We report a rare case of dengue fever triggering systemic lupus erythematosus and lupus nephritis. The patient presented herself during a large outbreak of dengue fever in December 2012 in Maharashtra, India. The diagnosis of dengue fever was confirmed by the presence of NS-1 antigen during the first few days of febrile illness. Eight weeks later, kidney tissue biopsy studies revealed evidence of lupus nephritis on microscopic examination and immunofluorescence. The report interpreted it as focal proliferative glomerulonephritis and segmental sclerosis (Stage IIIC). The case was also found positive for perinuclear antineutrophil cytoplasmic antibodies by indirect immunofluorescence assay. An active and effective management of a case essentially calls for clear perception of differentiating dengue-induced lupus flare, antineutrophil cytoplasmic antibody-related nephropathy, and/or dengue-induced de-novo lupus disease. Dengue viremia may be the trigger for immune complex formation in patients who are predisposed to developing autoimmune diseases. The present case explains the importance of considering the diagnosis of dengue-related lupus nephritis as an atypical occurrence in appropriate situations, as in this case. It would not be improper to regard this escalating disease as an expanded feature of dengue.Entities:
Keywords: autoimmune; de-novo lupus nephritis; dengue viremia; glomerulonephritis; kidney biopsy; lupus flare; segmental sclerosis
Year: 2013 PMID: 24204176 PMCID: PMC3818025 DOI: 10.2147/IMCRJ.S50708
Source DB: PubMed Journal: Int Med Case Rep J ISSN: 1179-142X
Laboratory parameters during course of lupus nephritis development
| Parameters | Normal range | Initial presentation with dengue fever (before lupus development) | Development of lupus nephritis (8 weeks later) | 10-week follow-up – post lupus therapy |
|---|---|---|---|---|
| Hemoglobin (gm/dL) | 12–16 | 9.9 | 10.0 | 14.3 |
| Leucocyte count (/mm3) | 4,000–10,500 | 6,060 | 9,270 | 11,100 |
| Platelet count (lac/mm3) | 1.5–4.5 | 0.60 | 3.98 | 3.34 |
| Hematocrit (%) | 37–50 | 32.3 | 29.9 | 32 |
| ESR | Up to 20 | 20 | 74 | 38 |
| Urea (mg %) | 15–35 | 16 | 18 | 32 |
| Serum creatinine (mg %) | 0.6–1.3 | 1.0 | 0.9 | 0.8 |
| Serum sodium (mE/L) | 135–145 | 133 | 134 | 140 |
| Serum potassium (mE/L) | 3.5–5.5 | 3.8 | 4.1 | 3.6 |
| SGPT (U/L) | 5–55 | 25 | 24 | 51 |
| SGOT (U/L) | 5–55 | 35 | 33 | 23 |
| Total protein (gm %) | 6.2–8.4 | 6.9 | 6.5 | 7.0 |
| Albumin (gm %) | 3.5–5.0 | 2.5 | 2.6 | 3.8 |
| Globulin (gm/dL) | 2–4 | 4.4 | 4.4 | 3.2 |
| CPK total (IU/L) | 60–400 | Not done | Not done | 51 |
| Urine microscopy | Absent proteins, cells, casts | Trace proteins, no casts | 3+ proteins, 2–3 RBCs/HPF, no casts | Trace proteins, no casts |
| 24-hour urinary protein (mg/24h) | <300 | Not done | 1,130 | 422 |
| ANA (immunofluorescence) | – | Not done | Positive (homogenous) 1:2,560 | Positive (homogenous) 1:80 |
| Anti-dsDNA (immunofluorescence) | – | Not done | Positive 1:80 | Negative |
| Complement C3 (mg/dL) | 90–180 | Not done | 105 | 76.2 |
| Complement C4 (mg/dL) | 10–40 | Not done | 18 | 15.8 |
| Coombs test (direct and indirect) | Negative | Not done | Negative | Negative |
| p-ANCA (IIF) | – | Not done | Strongly positive 1:320 | Weakly positive 1:80 |
| IHC, ISH – dengue RNA virus in tissue biopsy | – | Not done | Negative |
Abbreviations: ANA, antinuclear antibody; Anti-dsDNA, anti-double-stranded deoxyribonucleic acid; CPK, creatine phosphokinase; ESR, erythrocyte sedimentation rate; HPF, high power field; IHC, immunohistochemistry; IIF, indirect immunofluorescence; ISH, in situ hybridization; p-ANCA, perinuclear antineutrophil cytoplasmic antibody; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic pyruvic transferase; RBC, red blood cell.